Borrelia burgdorferi genotype predicts the capacity for hematogenous dissemination during early lyme disease

Journal of Infectious Diseases

Volumn 198, Issue 9, 2008, Pages 1358-1364

  Wormser, Gary P ^a   Brisson, Dustin ^b   Liveris, Dionysios ^a   Hanincová, Klára ^a   Sandigursky, Sabina ^a   Nowakowski, John ^a   Nadelman, Robert B ^a   Ludin, Sara ^a   Schwartz, Ira ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MEMBRANE PROTEIN; OUTER SURFACE PROTEIN C; RNA 16S; RNA 23S; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BACTERIUM ISOLATE; BLOOD CULTURE; BORRELIA BURGDORFERI; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA SEQUENCE; ERYTHEMA CHRONICUM MIGRANS; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENOTYPE; HUMAN; HUMAN TISSUE; IXODES SCAPULARIS; LYME DISEASE; MAJOR CLINICAL STUDY; NONHUMAN; POLYMERASE CHAIN REACTION; PREDICTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SKIN CULTURE; SUBURBAN AREA; UNITED STATES;

ANIMALS; BORRELIA BURGDORFERI; GENOTYPE; HUMANS; IXODES; LYME DISEASE; NEW YORK CITY; NYMPH;

EID: 54249105325     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/592279     Document Type: Article

References (38)

1. Nadelman RB, Wormser GP. Lyme borreliosis. Lancet 1998; 352:557-65.
2. Stanek G, Strle F. Lyme borreliosis. Lancet 2003; 362:1639-47.
3. Wang G, van Dam AP, Schwartz I, Dankert J. Molecular typing of Borrelia burgdorferi sensu lato: taxonomic, epidemiological, and clinical implications. Clin Microbiol Rev 1999; 12:633-53.
4. Piesman J, Gern L. Lyme borreliosis in Europe and North America. Parasitology 2004; 129(Suppl 1):S191-220.
5. Wang G, van Dam AP, Dankert J. Phenotypic and genetic characterization of a novel Borrelia burgdorferi sensu lato isolate from a patient with Lyme borreliosis. J Clin Microbiol 1999; 37:3025-8.
6. Richter D, Schlee DB, Allgower R, Matuschka FR. Relationships of a novel Lyme disease spirochete, Borrelia spielmani sp. nov., with its hosts in Central Europe. Appl Environ Microbiol 2004; 70:6414-9.
7. Liveris D, Gazumyan A, Schwartz I. Molecular typing of Borrelia burgdorferi sensu lato by PCR-restriction fragment length polymorphism analysis. J Clin Microbiol 1995; 33:589-95.
8. Liveris D, Varde S, Iyer R, et al. Genetic diversity of Borrelia burgdorferi in Lyme disease patients as determined by culture versus direct PCR with clinical specimens. J Clin Microbiol 1999; 37:565-9.
9. Seinost G, Dykhuizen DE, Dattwyler RJ, et al. Four clones of Borrelia burgdorferi sensu stricto cause invasive infection in humans. Infect Immun 1999; 67:3518-24.
10. Wang IN, Dykhuizen DE, Qiu W, Dunn JJ, Bosler EM, Luft BJ. Genetic diversity of ospC in a local population of Borrelia burgdorferi sensu stricto. Genetics 1999; 151:15-30.
11. Brisson D, Dykhuizen DE. ospC diversity in Borrelia burgdorferi: different hosts are different niches. Genetics 2004; 168:713-22.
12. Brisson D, Dykhuizen DE, Ostfeld RS. Conspicuous impacts of inconspicuous hosts on the Lyme disease epidemic. Proc Biol Sci 2008; 275:227-35.
13. Hanincová K, Ogden NH, Diuk-Wasser M, et al. Fitness variation of Borrelia burgdorferi sensu stricto strains in mice. Appl Environ Microbiol 2007; 74:153-7.
14. Hanincová K, Kurtenbach K, Diuk-Wasser M, Brei B, Fish D. Epidemic spread of Lyme borreliosis, northeastern United States. Emerg Infect Dis 2006; 12:604-11.
15. Wormser GP, Liveris D, Nowakowski J, et al. Association of specific subtypes of Borrelia burgdorferi with hematogenous dissemination in early Lyme disease. J Infect Dis 1999; 180:720-5.
16. Jones KL, Glickstein LJ, Damle N, Sikand VK, McHugh G, Steere AC. Borrelia burgdorferi genetic markers and disseminated disease in patients with early Lyme disease. J Clin Microbiol 2006; 44:4407-13.
17. Earnhart CG, Buckles EL, Dumler JS, Marconi RT. Demonstration of OspC type diversity in invasive human Lyme disease isolates and identification of previously uncharacterized epitopes that define the specificity of the OspC murine antibody response. Infect Immun 2005; 73:7869-77.
18. Alghaferi MY, Anderson JM, Park J, et al. Borrelia burgdorferi ospC heterogeneity among human and murine isolates from a defined region of northern Maryland and southern Pennsylvania: lack of correlation with invasive and noninvasive genotypes. J Clin Microbiol 2005; 43:1879-84.
19. Schwartz I, Wormser GP, Schwartz JJ, et al. Diagnosis of early Lyme disease by polymerase chain reaction amplification and culture of skin biopsies from erythema migrans lesions. J Clin Microbiol 1992; 30:3082-8.
20. Liveris D, Wang G, Girao G, et al. Quantity of Borrelia burgdorferi detected in 2 mm skin samples of erythema migrans lesions: correlation with clinical and laboratory findings. J Clin Microbiol 2002; 40:1249-53.
21. Qiu WG, Dykhuizen DE, Acosta MS, Luft BJ. Geographic uniformity of the Lyme disease spirochete (Borrelia burgdorferi) and its shared history with tick vector (Ixodes scapularis) in the northeastern United States. Genetics 2002; 160:833-49.
22. Wang G, Ojaimi C, Iyer R, et al. Impact of genotypic variation of Borrelia burgdorferi sensu stricto on kinetics of dissemination and severity of disease in C3H/HeJ mice. Infect Immun 2001; 69:4303-12.
23. Wang G, Ojaimi C, Wu H, et al. Disease severity in a murine model of Lyme borreliosis is associated with the genotype of the infecting Borrelia burgdorferi sensu stricto strain. J Infect Dis 2002; 186:782-91.
24. Dykhuizen DE, Brisson D, Sandigursky S, et al. The propensity of different Borrelia burgdorferi sensu stricto genotypes to cause disseminated infections in humans. Am J Trop Med Hyg 2008; 78:806-10.
25. Sokal RR, Rohlf FJ. Biometry. New York: WH Freeman, 1995.
26. Hope ACA. A simplified Monte Carlo significance test procedure. J Royal Stat Soc B 1968; 30:582-98.
27. R Development Core Team. R: a language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing, 2005.
28. Brisson D. Effect of host community composition on the diversity and abundance of Lyme disease [PhD thesis]. Stony Brook, NY: Stony Brook University, 2006.
29. Attie O, Bruno JF, Xu Y, Qiu D, Luft BJ, Qiu WG. Co-evolution of the outer surface protein C gene (ospC) and intraspecific lineages of Borrelia burgdorferi sensu stricto in the northeastern United States. Infect Genet Evol 2007; 7:1-12.
30. Bunikis J, Garpmo U, Tsao J, Berglund J, Fish D, Barbour AG. Sequence typing reveals extensive strain diversity of the Lyme borreliosis agents Borrelia burgdorferi in North America and Borrelia afzelii in Europe. Microbiology 2004; 150:1741-55.
31. Qiu WG, Schutzer SE, Bruno JF, et al. Genetic exchange and plasmid transfers in Borrelia burgdorferi sensu stricto revealed by three-way genome comparisons and multilocus sequence typing. Proc Natl Acad Sci USA 2004; 101:14150-5.
32. Dykhuizen DE, Baranton G. The implications of a low rate of horizontal transfer in Borrelia. Trends Microbiol 2001; 9:344-50.
33. Dykhuizen DE, Polin DS, Dunn JJ, et al. Borrelia burgdorferi is clonal: implications for taxonomy and vaccine development. Proc Natl Acad Sci USA 1993; 90:10163-7.
34. Grimm D, Tilly K, Byram R, et al. Outer-surface protein C of the Lyme disease spirochete: a protein induced in ticks for infection of mammals. Proc Natl Acad Sci USA 2004; 101:3142-7.
35. Pal U, Yang X, Chen M, et al. OspC facilitates Borrelia burgdorferi invasion of Ixodes scapularis salivary glands. J Clin Invest 2004; 113:220-30.
36. Bacon RM, Biggerstaff BJ, Schriefer ME, et al. Serodiagnosis of Lyme disease by kinetic enzyme-linked immunosorbent assay using recombinant VlsE1 or peptide antigens of Borrelia burgdorferi compared with 2-tiered testing using whole-cell lysates. J Infect Dis 2003; 187:1187-99.
37. Nowakowski J, Schwartz I, Liveris D, et al. Laboratory diagnostic techniques for patients with early Lyme disease associated with erythema migrans: a comparison of different techniques. Clin Infect Dis 2001; 33:2023-7.
38. Wilske B, Fingerle V, Schulte-Spechtel U. Microbiological and serological diagnosis of Lyme borreliosis. FEMS Immunol Med Microbiol 2007; 49:13-21.